3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Rectal Neoplasms
5
Colorectal Neoplasms
4
Barrett Esophagus
3
Adenocarcinoma Of Esophagus
3
Stomach Neoplasms
2
Nasopharyngeal Carcinoma
2
Esophageal Neoplasms
2
Colorectal Neoplasms, Hereditary Nonpolyposis
2
Colonic Neoplasms
2
Urogenital Neoplasms
1
Upper Tract Urothelial Carcinoma
1
Squamous Cell Carcinoma of Head and Neck
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Neoplasms
1
Lymphoma, Primary Effusion
1
Lymphoma, B-Cell
1
Lymphoma, AIDS-Related
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Fistula
1
Esophageal Squamous Cell Carcinoma
1
Disease
1
Colitis
1
Clinical Stage III Gastric Cancer AJCC v8
1
Carcinoma, Non-Small-Cell Lung
1
Bacteremia
1
Adenoma
1
Adenocarcinoma
1
Interventions
Carboplatin
5
pembrolizumab
3
Paclitaxel
3
Observation
3
Capecitabine
3
Azacitidine
3
venetoclax
2
pertuzumab
2
olaparib
2
durvalumab
2
Tretinoin
2
Trastuzumab
2
Standard of Care
2
Oxaliplatin
2
Irinotecan
2
Immunotherapy
2
Chemoradiotherapy
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
toripalimab
1
tislelizumab
1
tegafur-gimeracil-oteracil
1
taxane
1
talazoparib
1
tagraxofusp
1
sarilumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Endoscopy
×
1 year
×
Clear all
NCT07472868
2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3
Not yet recruiting
394 enrolled